<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">global-journal-of-science-frontier-research-i-interdisciplinary</journal-id>
<journal-title-group>
<journal-title>Global Journal of Science Frontier Research - I: Interdisciplinary</journal-title>
</journal-title-group>
<issn publication-format="print">0975-5896</issn>
<issn publication-format="electronic">2249-4626</issn>
<publisher><publisher-name>Global Journals Publishing Group Incorporated</publisher-name></publisher>
<self-uri xlink:href="https://globaljournals.org/journal-seo-export/jats/58504.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">58504</article-id>
<title-group>
<article-title>SARS-Cov-2 and the Case for Empirical Treatment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Watkins</surname><given-names>Alexandria</given-names></name><xref ref-type="aff" rid="aff1" />
</contrib>
<contrib contrib-type="author"><name><surname>Bartlett</surname><given-names>Richard P.</given-names></name></contrib>
</contrib-group>
<aff id="aff1">UNITED STATES</aff>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2020-08-11">
<day>11</day>
<month>08</month>
<year>2020</year>
</pub-date>
<volume>20</volume>
<issue>I4</issue>
<fpage>1</fpage>
<lpage>8</lpage>
<abstract><p>Abstract not found</p></abstract>
<kwd-group kwd-group-type="author-generated">
<kwd>steroids and coronavirus</kwd>
<kwd>the United States with unique cases.</kwd>
</kwd-group>
<self-uri content-type="pdf" xlink:href="https://globaljournals.org/GJSFR_Volume20/1-SARS-Cov-2.pdf" />
<self-uri content-type="html" xlink:href="https://globaljournals.org/scholarly-articles/sars-cov-2-and-the-case-for-empirical-treatment/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>As of June 17, 2020, Google Trends reports that the topics &quot;steroids and coronavirus&quot; have increased +4,750%.12 This is an outpatient case study that examines two patients in the United States with unique cases that involve oncology and Severe Acute Respiratory Syndrome Coronavirus-2 (SARSCoV- 2), also known as COVID-19. This case study aims to reveal the identification process, diagnosis, clinical course, and management of such a distinctive case - including the patient&#039;s prodromal phase and subsequent progression of the disease in an outpatient setting utilizing telemedicine. The goal is to call attention to the success of proactive, early empirical treatment, combining a classic corticosteroid (budesonide) administered via a nebulizer and an oral macrolide antibiotic known as clarithromycin (Biaxin).</p>
</sec>
</body>
</article>